N-[(2-chlorophenyl)methyl]-2-[3-methyl-4-oxo-7-(pyrrolidine-1-sulfonyl)-3,4-dihydro-1,5-benzothiazepin-5(2H)-yl]acetamide
Chemical Structure Depiction of
N-[(2-chlorophenyl)methyl]-2-[3-methyl-4-oxo-7-(pyrrolidine-1-sulfonyl)-3,4-dihydro-1,5-benzothiazepin-5(2H)-yl]acetamide
N-[(2-chlorophenyl)methyl]-2-[3-methyl-4-oxo-7-(pyrrolidine-1-sulfonyl)-3,4-dihydro-1,5-benzothiazepin-5(2H)-yl]acetamide
Compound characteristics
| Compound ID: | G640-0565 |
| Compound Name: | N-[(2-chlorophenyl)methyl]-2-[3-methyl-4-oxo-7-(pyrrolidine-1-sulfonyl)-3,4-dihydro-1,5-benzothiazepin-5(2H)-yl]acetamide |
| Molecular Weight: | 508.06 |
| Molecular Formula: | C23 H26 Cl N3 O4 S2 |
| Smiles: | CC1CSc2ccc(cc2N(CC(NCc2ccccc2[Cl])=O)C1=O)S(N1CCCC1)(=O)=O |
| Stereo: | RACEMIC MIXTURE |
| logP: | 3.9381 |
| logD: | 3.9381 |
| logSw: | -4.1617 |
| Hydrogen bond acceptors count: | 10 |
| Hydrogen bond donors count: | 1 |
| Polar surface area: | 72.221 |
| InChI Key: | MYOPTNDHGOSASA-INIZCTEOSA-N |